• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哈萨克斯坦 2005-2019 年特定分期肾癌发病率趋势。

Trends in Stage-Specific Kidney Cancer Incidence in Kazakhstan, 2005-2019.

机构信息

Research Institute of Life and Health Sciences, Higher School of Medicine, Kokshetau University named after Sh. Ualikhanov, Kokshetau, Kazakhstan.

Central Asian Institute for Medical Research, Astana, Kazakhstan.

出版信息

Asian Pac J Cancer Prev. 2024 Sep 1;25(9):3239-3249. doi: 10.31557/APJCP.2024.25.9.3239.

DOI:10.31557/APJCP.2024.25.9.3239
PMID:39342603
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11700335/
Abstract

OBJECTIVE

The aim is to analyze the incidence of kidney cancer over a 15-year period, considering factors such as stage, age, sex, and morphological verification in the regional context in Kazakhstan.

METHODS

The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted methodology used in sanitary statistics. The data were used to calculate the average percentage change (APС) using the Joinpoint regression analysis to determine the trend over the study period.

RESULTS

Among the meticulously documented 15,277 cases, a conspicuous male predominance was noted, comprising 53.7% of cases compared to 46.3% in females, with peak incidences observed within the 50-69 age cohorts. The average age at diagnosis exhibited a progressive rise over the study period, with discernible variations observed in age-specific incidence rates, particularly pronounced within the 60-84 age brackets. Noteworthy temporal trends indicated a consistent uptick in crude incidence rates, with distinct regional disparities manifesting higher rates in northern regions relative to their southern and western counterparts. Stratification by cancer stage unveiled a significant surge in stages I-II cases alongside a concomitant decrement in stage III incidences, complemented by reductions in stage IV occurrences and instances of unspecified disease stages. Morphological verification rates displayed regional variations, with an overarching ascending trajectory across most regions, albeit exceptions noted, notably in the Kyzylorda region.

CONCLUSION

Our study identified a rise in kidney cancer incidence in Kazakhstan, likely reflecting global trends driven by increased risk factor exposure and incidental imaging findings. Regional disparities and varied stage distributions highlight the complexity of kidney cancer epidemiology. Despite advancements in early detection, delayed diagnosis persists, necessitating improved surveillance and diagnostic practices.

摘要

目的

分析哈萨克斯坦地区 15 年来肾脏肿瘤的发病情况,考虑分期、年龄、性别和形态学验证等因素。

方法

本研究采用描述性和分析性肿瘤流行病学方法进行回顾性研究。根据卫生统计学中普遍使用的方法,确定广泛的、粗的和年龄特异性发病率。使用这些数据,通过 Joinpoint 回归分析计算平均百分比变化(APС),以确定研究期间的趋势。

结果

在精心记录的 15277 例病例中,男性明显居多,占 53.7%,女性占 46.3%,发病高峰出现在 50-69 岁年龄组。诊断时的平均年龄在研究期间呈上升趋势,年龄特异性发病率存在明显差异,60-84 岁年龄组尤为明显。值得注意的时间趋势表明,粗发病率持续上升,且存在明显的区域差异,北部地区的发病率明显高于南部和西部地区。按癌症分期分层,I-II 期病例显著增加,同时 III 期病例减少,IV 期病例减少,未指明疾病分期的病例减少。形态学验证率存在区域差异,大多数地区呈上升趋势,但也有例外,尤其是克孜勒奥尔达州。

结论

本研究发现哈萨克斯坦肾脏肿瘤发病率上升,可能反映了全球因危险因素暴露和偶然影像学发现而导致的发病率上升趋势。区域差异和不同的分期分布突出了肾脏肿瘤流行病学的复杂性。尽管早期检测有所进展,但仍存在延迟诊断的情况,因此需要改进监测和诊断实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/46a15fba0d99/APJCP-25-3239-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/36437af4428d/APJCP-25-3239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/608571b77ebb/APJCP-25-3239-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/12a2c7652869/APJCP-25-3239-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/c04b79cb9b71/APJCP-25-3239-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/46a15fba0d99/APJCP-25-3239-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/36437af4428d/APJCP-25-3239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/608571b77ebb/APJCP-25-3239-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/12a2c7652869/APJCP-25-3239-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/c04b79cb9b71/APJCP-25-3239-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca7/11700335/46a15fba0d99/APJCP-25-3239-g005.jpg

相似文献

1
Trends in Stage-Specific Kidney Cancer Incidence in Kazakhstan, 2005-2019.哈萨克斯坦 2005-2019 年特定分期肾癌发病率趋势。
Asian Pac J Cancer Prev. 2024 Sep 1;25(9):3239-3249. doi: 10.31557/APJCP.2024.25.9.3239.
2
Liver Cancer Incidence in Kazakhstan: Fifteen-Year Retrospective Study.哈萨克斯坦的肝癌发病率:十五年回顾性研究。
Asian Pac J Cancer Prev. 2024 May 1;25(5):1763-1775. doi: 10.31557/APJCP.2024.25.5.1763.
3
Epidemiology of Lung Cancer in Kazakhstan: Trends and Geographic Distribution.哈萨克斯坦肺癌的流行病学:趋势和地理分布。
Asian Pac J Cancer Prev. 2023 May 1;24(5):1521-1532. doi: 10.31557/APJCP.2023.24.5.1521.
4
Lymphosarcoma Incidence in Kazakhstan: A Retrospective Survey (2010-2019).哈萨克斯坦淋巴肉瘤发病率:回顾性调查(2010-2019 年)。
Asian Pac J Cancer Prev. 2023 Jun 1;24(6):1885-1896. doi: 10.31557/APJCP.2023.24.6.1885.
5
Epidemiology of Breast Cancer Mortality in Kazakhstan, trends and Geographic Distribution.哈萨克斯坦乳腺癌死亡率的流行病学,趋势和地理分布。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3361-3371. doi: 10.31557/APJCP.2023.24.10.3361.
6
Colorectal Cancer Mortality in Kazakhstan: Spatio-Temporal Epidemiological Assessment.哈萨克斯坦结直肠癌死亡率:时空流行病学评估。
Asian Pac J Cancer Prev. 2022 Mar 1;23(3):953-960. doi: 10.31557/APJCP.2022.23.3.953.
7
New Trends of Cervical Cancer Incidence in Kazakhstan.哈萨克斯坦宫颈癌发病率的新趋势。
Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1295-1304. doi: 10.31557/APJCP.2021.22.4.1295.
8
Trend in Gastric Cancer Mortality in Kazakhstan.哈萨克斯坦胃癌死亡率趋势。
Asian Pac J Cancer Prev. 2022 Nov 1;23(11):3779-3789. doi: 10.31557/APJCP.2022.23.11.3779.
9
Global, regional, and national burden and trends of kidney cancer associated with high BMI from 1990 to 2021: Findings from the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家与高体重指数相关的肾癌负担及趋势:全球疾病负担研究2021的结果
PLoS One. 2025 Mar 24;20(3):e0320185. doi: 10.1371/journal.pone.0320185. eCollection 2025.
10
Increasing kidney cancer incidence and survival in Estonia: role of age and stage.爱沙尼亚的肾癌发病率和生存率不断上升:年龄和分期的作用。
Acta Oncol. 2019 Jan;58(1):21-28. doi: 10.1080/0284186X.2018.1512158. Epub 2018 Oct 3.

本文引用的文献

1
Development and validation of a nomogram for predicting the impact of tumor size on cancer-specific survival of locally advanced renal cell carcinoma: a SEER-based study.基于 SEER 数据库的研究:建立并验证预测局部进展期肾细胞癌肿瘤大小对癌症特异性生存影响的列线图。
Aging (Albany NY). 2024 Feb 19;16(4):3823-3836. doi: 10.18632/aging.205562.
2
Lymphosarcoma Incidence in Kazakhstan: A Retrospective Survey (2010-2019).哈萨克斯坦淋巴肉瘤发病率:回顾性调查(2010-2019 年)。
Asian Pac J Cancer Prev. 2023 Jun 1;24(6):1885-1896. doi: 10.31557/APJCP.2023.24.6.1885.
3
Epidemiology of Lung Cancer in Kazakhstan: Trends and Geographic Distribution.
哈萨克斯坦肺癌的流行病学:趋势和地理分布。
Asian Pac J Cancer Prev. 2023 May 1;24(5):1521-1532. doi: 10.31557/APJCP.2023.24.5.1521.
4
Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends.哈萨克斯坦子宫体癌:近期发病趋势。
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):849-857. doi: 10.31557/APJCP.2023.24.3.849.
5
Evaluation of Breast Cancer Incidence Trends in the Karaganda Region of Kazakhstan.哈萨克斯坦卡拉干达地区乳腺癌发病率趋势评估
Iran J Public Health. 2022 Oct;51(10):2308-2316. doi: 10.18502/ijph.v51i10.10989.
6
Studying the association between breast cancer and renal cell carcinoma.研究乳腺癌和肾细胞癌之间的关联。
Breast Cancer Res Treat. 2022 Feb;191(3):643-652. doi: 10.1007/s10549-021-06465-4. Epub 2021 Dec 2.
7
Trends of Colorectal Cancer Incidence in Kazakhstan.哈萨克斯坦结直肠癌发病率趋势
Asian Pac J Cancer Prev. 2021 Oct 30;22(10):3405. doi: 10.31557/APJCP.2021.22.10.3405.
8
Impact of Screening on Breast Cancer Incidence in Kazakhstan: Results of Component Analysis.哈萨克斯坦的筛查对乳腺癌发病率的影响:组分分析结果。
Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2807-2817. doi: 10.31557/APJCP.2021.22.9.2807.
9
Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma.晚期肾细胞癌患者的流行病学、风险评估和生物标志物。
Urol Clin North Am. 2020 Aug;47(3):293-303. doi: 10.1016/j.ucl.2020.04.002. Epub 2020 Jun 10.
10
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years.20-39 岁年轻成年人肾癌发病率和趋势。
Cancer Epidemiol. 2020 Aug;67:101762. doi: 10.1016/j.canep.2020.101762. Epub 2020 Jun 22.